Background Although malaria is a leading cause of child deaths, few well-documented estimates of its direct and indirect burden exist. Our objective was to estimate the number of deaths directly attributable to malaria among children ,5 years old in sub-Saharan Africa for the year 2000.
Introduction
Malaria is a leading cause of mortality among children in sub-Saharan Africa. Valid quantitative estimates of malaria mortality are useful for monitoring the impact of prevention and control activities, targeting interventions, and advocacy. Unfortunately, vital registration systems in most countries in sub-Saharan Africa have low coverage and do not produce dependable estimates. mortality rate, from studies identified in a literature review, was applied to these malaria-risk populations to produce an estimate of~766 000 deaths among children ,5 years old in sub-Saharan Africa for 1995. This model was recently revised to account for variations in malaria transmission intensity 10 and urbanization, 11 resulting in estimates of 742 000 and 680 000 child malaria deaths, respectively, for the year 2000.
Although these latter models were superior to previous ones, not all contemporary data were used, and use of the median to estimate the malaria mortality rate assumed all studies had equal precision and did not permit an investigation of factors that might have led to a prediction model that could better account for inter-country differences and time trends.
Our objective was to estimate the number of 'direct' malaria deaths for children ,5 years old in sub-Saharan Africa for the year 2000 by refining the models by Snow et al. 8, 10, 11 and using all available contemporary mortality data. By direct malaria death, we mean that malaria was the underlying cause (i.e. 'the disease or injury which initiated the train of morbid events leading directly to death' 12 ). Our analysis does not attempt to quantify 'indirect' malaria deaths, in which malaria was a contributing cause (e.g. a child with malaria-associated anaemia dies after developing pneumonia, but neither the anaemia nor pneumonia would have been fatal in isolation); although we acknowledge that the burden of indirect malaria mortality is probably substantial. 13 Nor does our analysis quantify 'consequential' malaria deaths, in which consequences of clinical management (e.g. exposure to HIV during a blood transfusion) or malaria sequelae (e.g. epilepsy after cerebral malaria) lead to death. 10 The analysis was limited to Africa because this is where most malaria deaths (perhaps 80-90%) are thought to occur. 2, 14, 15 Additionally, we sought to identify research areas or information that might improve future estimates.
Methods

Overview
First, we conducted a literature review to identify studies of childhood malaria mortality. Second, for each country, we estimated sub-populations of children with different risks of dying from malaria for the year 2000. Third, we estimated a malaria mortality rate for each sub-population using studies from the literature review. To estimate rates, we developed a prediction model with covariates that were available from studies used in the prediction model and from countries to which the predicted rates would be applied. As there were almost no mortality studies with results for the year 2000, we used studies from the past two decades, included a covariate for study year in the prediction model, and estimated rates by giving the study year covariate a value to indicate the year 2000. Fourth, for each malaria risk sub-population in each country, we estimated malaria deaths by multiplying the subpopulation by its corresponding rate. Finally, we summed malaria deaths for all sub-populations from all countries.
Literature review
To identify studies of the causes of child deaths in Africa where malaria transmission occurs, we reviewed references used by Snow et al., 8 conducted an independent search of the PubMed database, consulted experts, and asked researchers for unpublished studies. For the PubMed search, we searched for all 'malaria/mortality' Medical Subject Headings, and within these references, searched for articles on infants (birth to 23 months) and preschool children (2-5 years). The inclusion criteria were that studies: (i) were community-based, (ii) had results that permitted a malaria mortality rate to be estimated, (iii) had a duration of a multiple of 12 months (malaria is highly seasonal), (iv) included children exactly 0-59 months old (malaria mortality is unevenly distributed in this age range), (v) had a proportion of deaths with no known cause ,30%, (vi) began in 1980 or later, and (vii) did not overlap with another study in the analysis in time and place. All studies used verbal autopsies (interviews with the deceased child's relatives are interpreted by clinicians or an algorithm) to determine causes of death, 16, 17 and we note that International
Classification of Diseases 12 rules might not have been used to determine causes of death. For studies that were intervention trials, only results from control groups were included. Some studies met nearly all inclusion criteria but had a minor limitation (e.g. duration 5 11 months). Therefore, we created two categories: Group A (studies meeting all inclusion criteria) and Group B (studies with minor limitations) ( Table 1) . For southern Africa, we included 16 estimates of the malaria mortality rate from disease surveillance reports, plus one community-based study of children 0-4 years ( Table 2) . To examine time trends, for multi-year studies, results were abstracted for individual years whenever possible; and, with one exception, results for all years were included. The exception was a 9-year study from Morogoro, Tanzania, 18, 19 which had some data completeness concerns; 20, 21 for this study, data for one recent year (2001) that were of good quality were included. Data from studies were abstracted onto standardized paper forms, double-entered into an electronic database, and validated. Key data elements (e.g. number of malaria deaths) were double-checked by two investigators. Data from disease surveillance reports from southern Africa were abstracted onto standardized paper forms and entered into an electronic database by one investigator.
Estimating populations at risk for malaria
We divided Africa into seven sub-populations ( Figure 1 ). As done by Snow et al., 8, 10 we first divided Africa into three regions: northern Africa (Algeria, Egypt, Libya, Morocco, and Tunisia; assumed to have no malaria deaths because the climate is generally unsuitable for P. falciparum transmission), southern Africa (Botswana, Lesotho, Namibia, South Africa, Swaziland, and Zimbabwe; very low malaria mortality rates assumed because of a less suitable climate and intense efforts to control the mosquito vector 22 ), and middle Africa (African countries in neither northern nor southern Africa; variable, including high, malaria mortality rates).
For middle and southern Africa, we used results from the Mapping Malaria Risk in Africa (MARA) project to estimate populations at risk for malaria in 2000. 8, 9, 23 Briefly, a grid of 5 · 5 km 2 was superimposed on a map of sub-Saharan Africa.
For each square, MARA estimated the 1990 population 24 and a 'climate suitability index' based on a fuzzy logic model of temperature and rainfall determinants of the parasite's sporogenic cycle and mosquito's survival. 25 The index describes the probability that the climate is suitable for P. falciparum transmission, and it varies continuously from 0 (probably unsuitable) to 1 (probably suitable). MARA results were applied to United Nations country population estimates for the year 2000. 26 Of the five middle Africa countries excluded from the MARA model, two were assumed to have no malaria deaths (Mauritius 15, 27 and Seychelles
28
) and three had populations at risk estimated from other sources (Cape Verde, 15, 28, 29 Comoros, 15, 28 and Sã o Tomé and Príncipe 15, 28, 30 ).
We categorized populations as being exposed to one of three levels of malaria transmission intensity: zero (populations with a MARA index 5 0), low intensity (index .0 and ,0.75), or high intensity (index >0.75). This categorization (developed by Snow et al. 10 ) was based on the observation that a MARA index ,0.75 generally corresponded to a parasite prevalence ,25% and an index >0.75 generally corresponded to a parasite prevalence >25%. 31 Parasite prevalence (percentage of a community-based sample of children who were parasitaemic with P. falciparum) was considered an approximate indicator for malaria transmission intensity and the malaria mortality rate. 32, 33 (For details, see the complete report, which is available on the Internet at: http://rbm.who.int/partnership/ wg/wg_monitoring/docs/CHERG_final_report.pdf) Results from our dataset suggested malaria mortality rates were lower in populations with low (,25%) parasite prevalence and generally higher in populations with high parasite prevalence ( Figure 2 ). This method does not explicitly include a category for epidemics. We assumed that much of what is called 'epidemic' malaria occurs in populations with low levels of endemic malaria transmission that occasionally have spikes of malaria deaths that appear to be epidemics. 'True' epidemic deaths (i.e. malaria deaths where no ongoing transmission occurs) were considered rare for a typical year (i.e. zero, for our estimates; although a sensitivity analysis explored the potential impact of epidemics-see model 'E' of Table 4 ). To estimate urban and rural populations for each malaria transmission category in each country, we used United Nations estimates of the proportion of all residents living in urban areas for 2000. 39 Because this source only provides national estimates, we assumed the proportion of a country's population living in urban areas was the same for populations exposed to zero, low-intensity, and high-intensity transmission. For the 40 middle African countries in the analysis, the median urban residence proportion was 33.4% (range: 6.2-84.0%). Urban residence proportions were based on census data and assumed to have no uncertainty (T. Buettner, personal communication, UN Population Division, October 29, 2003) .
Estimating malaria mortality rates for each at-risk sub-population
For middle Africa, results from mortality studies in middle African countries were analysed. To categorize studies as being from a low-intensity or high-intensity transmission area, we identified parasite prevalence values for all but six studies (Table 1) . Parasite prevalence >25% indicated high-intensity transmission, and prevalence ,25% indicated low-intensity transmission. Regarding the six mortality studies without a parasite prevalence value, three were from West Africa; [40] [41] [42] with a model of parasite prevalence for West Africa, 23, 43 we estimated that all three studies were in high-intensity transmission areas. The remaining studies (two from Ethiopia 44, 45 and one from Somalia 46 ) were excluded because the study sites were in areas with highly variable transmission levels and no conclusive determination could be made.
We calculated malaria mortality rates (expressed as deaths per 1000 children per year) with the formula: rate 5 malaria deaths/{person-time · [1 À (deaths with unknown causes/total deaths)]}. This expression ensures that the proportion of deaths attributable to malaria (PDAM) equals the malaria mortality rate divided by the all-cause mortality rate, and it assumes the PDAM for deaths with unknown causes equals the PDAM for deaths with known causes. 47 The calculation of mortality rates and all other analyses were performed with SAS version 8.0 (SAS Institute, Cary, NC). We did not adjust results for the potential bias introduced by verbal autopsy's imperfect sensitivity and specificity for identifying malaria deaths and that false-negatives probably do not equal false-positives. 17, 48 Although it is theoretically possible to correct this bias with sensitivity and specificity estimates from validation studies, 49 we did not believe that estimates of adequate quality and representativeness were available. 50 For middle Africa populations in rural areas with highintensity transmission, we ran a series of univariate Poisson regression models to identify covariates (obtainable for studies in our dataset and countries in middle Africa) that explained the large variation observed in malaria mortality rates and that could be used to predict rates for individual countries. Modelling was performed with the SAS GENMOD procedure, which uses generalized estimating equations (GEE) to account for over-dispersion of the rates and the potential correlation of mortality rates for individual years from the same study. 51, 52 For precision estimates, we used results from the empirical covariance matrix.
We examined the following covariates: study year (midpoint of data collection; analysed separately as a series of dichotomous and trichotomous variables); proportion of births attended by a health professional, as an indicator of health care access and infrastructure [source 5 surveys near study sites, e.g. province-level Demographic and Health Survey (DHS) Five other covariates were excluded: female literacy rate, access to clean water, study year as a continuous variable, coverage of three diphtheria-pertussis-tetanus vaccine doses (DPT3), and all-cause child mortality. Data on female literacy and access to water were not available for many studies. Study year (continuous variable) was excluded because it reflects both time and place (studies conducted in different years were often from different places) and, when study year is assumed to indicate time, outliers have a greater influence on model results. DPT3 coverage was excluded because, in our dataset, it increased from 1980 to 2001; therefore, we were concerned that study year and DPT3 coverage were collinear. All-cause child mortality, used in other disease burden models as an indicator of socioeconomic conditions, 53 was excluded because it 'contains' the malaria mortality rate and is, therefore, not very informative. In other words, a model with all-cause mortality models the malaria mortality rate with a 'noisy' version of itself. Additionally, in our dataset, all-cause child mortality was not significantly associated with malaria mortality. Significant (P-value , 0.05) covariates in the univariate analysis were entered into multivariate models; selected interactions were tested. For middle Africa populations in rural areas with lowintensity transmission, the five Group A studies from this population 18, 19, [54] [55] [56] [57] were analysed. The malaria mortality rate was estimated by a Poisson regression model (using the GEE approach described above) that only contained an intercept, which essentially pooled the five studies. This method was used to ensure the 95% confidence interval (95% CI) accounted for over-dispersion and correlation of the rates. To estimate urban rates for populations exposed to highintensity or low-intensity transmission, we first considered using studies of urban populations; however, too few studies were available. As an alternative, we multiplied the rural malaria mortality rate for a population in a particular country by an estimate of the urban-rural malaria mortality rate ratio (i.e. urban malaria mortality rate/rural malaria mortality rate) for that country. We estimated country-specific urban-rural malaria mortality rate ratios with the urban-rural 5 q 0 ratio (UR 5 q 0 R) (i.e. the country's 5 q 0 for urban populations/the country's 5 q 0 for rural populations, where 5 q 0 is the probability a live-born child dies before the age of 5 years). This method assumes the urban-rural mortality rate ratio is similar for malaria deaths and all non-malaria deaths. Although a rough assumption, we reasoned that if a main justification for adjusting for urban residence was that access to life-saving medical care was better in urban areas, such a benefit might exist for all major causes of child deaths. For southern Africa, we assumed no malaria deaths for populations exposed to low-intensity transmission. 8 For populations exposed to high-intensity transmission, we analysed data from 16 government disease surveillance reports from southern Africa, and one prospective, community-based study from South Africa of children 0-4 years that used verbal autopsies 58 ( Table 2) . As with studies from low-intensity transmission areas, the malaria mortality rate was estimated by an intercept-only Poisson regression model using the GEE approach. The use of surveillance reports was justified because the quality of surveillance data for malaria was generally good in southern Africa in the 1990s. 8 The use of all-age malaria mortality rates was justified because these populations have little acquired immunity against malaria, and malaria mortality rates are thought to be similar for all age groups. In fact, the malaria mortality rate of the one prospective study 58 of children (0.096 deaths per 1000 per year) was similar to the unweighted mean of the 16 estimates from the surveillance reports (0.155 deaths per 1000 per year).
Estimating precision
To estimate the precision of the number of malaria deaths, we derived a 95% CI formula using the delta method, 59 which estimates the variance of a function. We used the term 'precision estimate' instead of '95% CI' to remind readers that the interpretation of our precision estimate as a 95% CI rests on the assumption that the data were from a probability sample. Clearly, the data were not from a probability sample; but they are the best data we could find after an intensive search, and they are at least representative of some groups of children in malarious parts of Africa. Sources of uncertainty included were the precision of the malaria mortality rates in rural areas with high-intensity and low-intensity transmission (from the two Poisson models) and the urban adjustment factor, UR 5 q 0 R (from DHSs). (For details, see the complete report, which is available on the Internet at: http://rbm.who. int/partnership/wg/wg_monitoring/docs/CHERG_final_report. pdf) Uncertainty in population size and urban residence was not included because they were based on census data and precision estimates were not available. Uncertainty resulting from the non-representativeness of study sites and use of verbal autopsies was not included because the major type of uncertainty they could introduce is bias, not random error; and the delta method is designed only to combine multiple sources of random error. As the magnitude and direction of these potential biases were difficult to specify, we thought that attempts to make adjustments for them might introduce additional biases. Therefore, as mentioned above for verbal autopsies, no adjustments were made.
Sensitivity analyses
To examine the robustness of our results, we performed seven sensitivity analyses (brief descriptions in Table 4 ). (For details, see the complete report, which is available on the Internet at: http://rbm.who.int/partnership/wg/wg_monitoring/docs/ CHERG_final_report.pdf)
Results
Literature review
We identified 31 studies (20 in Group A and 11 in Group B; 16 in West Africa and 15 in East Africa) from 14 countries in middle Africa (Table 1 ) and 17 reports from four countries in southern Africa (Table 2) . Essentially no studies were identified for central Africa, and nearly all were from rural areas. Altogether, Group A and B studies from middle Africa included 4039 malaria deaths during 708 267 person-years of follow-up.
Populations at risk and malaria mortality rates
In 2000, among 111 million children in sub-Saharan Africa, 100 million lived in areas where malaria transmission occurred (Table 3) . About half (48 million) of these 100 million children lived in areas with the highest risk of dying from malaria-rural areas in middle Africa with high-intensity transmission.
In the analysis to estimate a malaria mortality rate for rural populations in middle Africa with high-intensity transmission, the only significant univariate associations were several dichotomous variables for study year. Although results for these variables were similar, the one with the best model fit coded study year as 1980-89 vs 1990 and later (rate of the 1990s1 period was 1.529 times the rate in the 1980s; 95% CI 1.165-2.007) (Figure 3) . Thus, the final prediction model included only study year (1980s vs 1990s1), and the rate for rural areas in middle Africa with high-intensity transmission was predicted to be constant from 1990-2001 for all countries: 11.36 deaths per 1000 children per year (95% CI 9.80-12.92) (Figure 3 and Table 3 , first row). For urban populations in middle Africa with high-intensity transmission, the rate was different for each country but generally about three-quarters of the rural rate (Table 3, The estimated malaria mortality rate for rural populations in middle Africa with low-intensity transmission was 2.31 deaths per 1000 per year (95% CI 2.11-2.51) (Table 3, third row). As above, the corresponding urban rate was about threequarters of the rural rate (Table 3 , fourth row). For southern Africa, we estimated a rate of 0.163 deaths per 1000 per year (95% CI 0.113-0.214) for areas with high-intensity transmission and assumed a rate of zero for areas with low-intensity transmission (Table 3 , rows 5 and 6).
Africa-wide mortality estimates
By summing deaths for the six sub-populations in Table 3 (Table 4 , first row).
Sensitivity analyses
The first five sensitivity analyses for middle Africa (Models B-E, Table 4 ) produced results that were remarkably similar to the 'best' model (Model A, Table 4 ). As expected, extreme CI 5 Confidence interval; 5 q 0 5 probability a live-born child will die before his or her fifth birthday. a Number of deaths may not exactly equal the product of a malaria mortality rate and its corresponding population at risk because of rounding. b See the 'Estimating precision' sub-section of the Methods for an explanation. assumptions led to estimates that were either considerably lower (Model F) or greater (Model G) than the 'best' estimate. The last sensitivity analysis for middle Africa (Model H, Table 4 ), based on the PDAM (conceptually, the malaria mortality rate/all-cause mortality rate), produced estimates that were considerably (36%) higher than the 'best' estimate. Model H probably overestimated malaria deaths because the PDAM was probably overestimated. The PDAM was probably overestimated because: (i) studies in the Model H analysis had all-cause mortality rates (the PDAM denominator) that were much (28.2%) lower than rates in the general population; 26 (For details, see the complete report, which is available on the Internet at: http://rbm.who.int/partnership/wg/wg_ monitoring/docs/CHERG_final_report.pdf) and (ii) as twothirds (10/15) of the studies had a malaria focus, we suspected that the malaria mortality rates (the PDAM numerator) from these studies probably did not greatly underestimate the rate in the general population (e.g. malaria-focused studies might have been more likely to be conducted in areas with high malaria mortality, or to classify deaths as malaria deaths). which corresponds to~1 058 000 malaria deaths (95% CI 759 000-1 651 000). Remarkably, when our malaria mortality rates were applied to the populations at risk estimated by Hay et al., 11 the result (802 373 deaths; precision estimate: 701 059-903 687) was nearly identical to our estimates. Our estimates have several important limitations. First, data from research sites are clearly not a probability sample of African children. If research sites were chosen because malaria was especially common, results (when generalized to the In contrast, burden might be underestimated if study populations had above-average socioeconomic status because they were located near a city or main roads or if the presence of the research project improved the population's health. A second limitation is the use of verbal autopsies. Although non-specific and insensitive, verbal autopsies do not introduce bias if false-positives (e.g. bacterial sepsis death incorrectly classified as malaria) equal false-negatives (e.g. death from malaria-related anaemia incorrectly classified as pneumonia). Unfortunately, verbal autopsy validation studies do not reveal a clear trend in the way verbal autopsies misclassify deaths. Depending on the study and diagnostic algorithm (some studies examined several algorithms), false-negatives can outnumber false-positives or vice versa. [61] [62] [63] [64] [65] Additionally, the finding that malaria mortality rates may decrease at high parasite prevalence levels [66] [67] [68] (For details, see the complete report, which is available on the Internet at: http://rbm.who.int/partnership/wg/wg_monitoring/ docs/CHERG_final_report.pdf) suggests that verbal autopsies may lose sensitivity in settings with high-intensity transmission (i.e. more false-negatives occur because more malaria deaths result from severe anaemia, which verbal autopsies may misclassify as pneumonia deaths). However, by defining transmission intensity with broad parasite prevalence categories, this potential problem probably was not an important source of bias for our estimates. A third limitation is that our methods require numerous assumptions, some with unknown validity. Fourth, some data had unknown validity and precision, e.g. population estimates, MARA results, parasite prevalence estimates, and covariate data used in the models. Although our assumptions and data almost certainly introduced biases, it is difficult to estimate their directions and magnitudes.
To address the preceding two limitations, at least partially, we conducted a variety of sensitivity analyses. We found the estimates were relatively insensitive to varying assumptions about the urban malaria mortality rate, urban population size, and deaths from epidemic malaria. In addition, the estimates changed little when we included studies with minor deviations from our ideal inclusion criteria. The estimates were, however, sensitive to extreme assumptions about deaths with unknown causes. The analysis based on the PDAM gave results that were much higher than our best estimates, but differences may be explained by the fact that all-cause mortality rates in study sites are not representative of the general population.
Finally, we caution readers that our precision estimates can only be interpreted as 95% CIs if the data are assumed to be a probability sample. Also, the precision estimates are probably too narrow, because they do not account for uncertainty in population size and urban residence.
For these reasons, our estimates should be considered an approximation of the true burden of direct malaria mortality. Information and data that might improve future estimates are listed in Box 1. Some issues are already being addressed. For example, the Global Rural Urban Mapping Programme, which distinguishes urban and rural areas with satellite-measured Box 1 Information that might improve future estimates of malaria mortality Better understanding of the relationship between verbal autopsy results and true malaria deaths (e.g. a verbal autopsy validation study conducted in a community setting)
Better understanding of how malaria mortality rates from research sites differ from rates in the general population Community-based, longitudinal data on the malaria mortality rate in central Africa Better definitions of and data on: -Malaria transmission intensity (and a better understanding of how transmission intensity affects malaria mortality)
-Urban populations (and a better understanding of how urban residence, including different types of urban residence, affects malaria mortality) -Malaria's indirect impact on mortality -The impact of malaria epidemics on malaria mortality (e.g. community-based, longitudinal data on malaria mortality during epidemics)
Better estimates of the size of populations at risk for malaria, especially sub-populations that potentially have different levels of mortality risk, such as: -Populations living in areas with higher vs lower levels of malaria transmission intensity -Urban and rural populations -Populations exposed to malaria interventions (e.g. insecticide-treated bednets) night-time light levels, is being used to provide more precise estimates of urban and rural populations.
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How should our results be used? First, it is probably safe to say that in 2000, a rough approximation of the burden of direct malaria mortality among children ,5 years old in subSaharan Africa was between 700 000 and 900 000 deaths. Second, the validity of estimates for specific countries is even more questionable than for continental estimates. Third, our results cannot be reliably extrapolated to years outside those in the dataset (e.g. if the child population in 2005 is 5% higher than in 2000, increasing our estimates by 5% may not provide a valid estimate for 2005). Fourth, our results should not be used to monitor trends in malaria mortality over time by comparing our estimates with other estimates based on different methods and data. For example, it would be inappropriate to conclude that malaria mortality had increased because our estimate for the year 2000 (803 620 deaths) is higher than the estimate by Snow et al. 8 for 1995 (765 775 deaths). Fifth, our results should not be used to estimate how many deaths would be prevented if malaria transmission were reduced or eliminated. Such estimates would probably be a gross underestimate because they do not include the large burden of indirect malaria mortality. Studies in Kenya, Nigeria, and Tanzania from the 1950s and 1970s found that after malaria transmission was drastically reduced with insecticide spraying, which would have had little or no effect on other causes of child mortality, all-cause mortality rates for infants and children 1-4 years old decreased by as much as 40-50%. [69] [70] [71] Similarly, when malaria chemoprophylaxis and insecticide-treated nets were used to prevent malaria in The Gambia, the all-cause child mortality rate decreased by 42%. 72 Finally, caution should be exercised in using our results to evaluate malaria prevention and control efforts, such as those of the Roll Back Malaria partnership. Such an evaluation would presumably involve repeating our estimation method using similar data after interventions were implemented with reasonably high coverage. However, if the interpretation of verbal autopsies remains unchanged, even if malaria were eradicated, verbal autopsy's high falsepositive rate will show erroneously that malaria is present. In 2000, when coverage of most interventions was very low, false-positives were 'helpful' because they partially counterbalanced false-negatives; but as coverage increases and the malaria burden is reduced and false-negatives disappear, one is left with 'unpreventable' malaria-like deaths (false-positives due to bacterial infections, etc., that could not be prevented with malaria-specific interventions). Such results would underestimate the impact of malaria prevention and control efforts.
Our results suggest that malaria mortality rates have increased between the 1980s and 1990s, although we were unable to find a difference between West and East Africa [results not shown (For details, see the complete report, which is available on the Internet at: http://rbm.who.int/partnership/ wg/wg_monitoring/docs/CHERG_final_report.pdf)].
It is important to remember, however, that 'study year' may also represent study place. In other words, increasing mortality rates may simply reflect a trend in which areas with higher malaria mortality rates were more often selected as study sites in the 1990s relative to the 1980s. However, some studies lasting many years found increasing trends, 55 with increasing resistance to the commonly-used antimalarial, chloroquine, often cited as the cause. 35, 55, 68, 73 In conclusion, we do not know how many direct malaria deaths occurred among children in sub-Saharan Africa in 2000. However, our study has several strengths: we conducted an intensive literature search, selected studies with rigorous inclusion criteria, introduced stringent quality controls on the data abstraction process, incorporated a novel approach to account for urbanization, utilized a statisticallybased method for estimating uncertainty, and made extensive use of sensitivity analyses to evaluate assumptions. Although the results are clearly imperfect, we hope that they are less imperfect, and methods more transparent, than earlier efforts.
One important byproduct of this work is a better understanding of the inadequacy of current data as a basis for developing estimates and measuring the impact of malaria interventions. Relatively few data of adequate quality could be identified, and no data were found for vast geographical areas with some of the world's poorest populations. 74 Sound epidemiological estimates are an essential part of public health decision-making. More and better studies are needed to support prevention and control programmes addressing malaria, which is directly responsible for~18% of all child deaths in sub-Saharan Africa.
